Congenital Long-QT Syndromes: A Clinical and Genetic Update From Infancy Through Adulthood
Long-QT syndromes (LQTSs) have been described in all ages and are a significant cause of cardiovascular mortality, especially in structurally normal hearts. Abnormalities in transmembrane ion conduction channels and structural proteins produce these clinical syndromes, labeled LQT1-LQT12; however, genotype-positive patients still represent only about 70% of LQTSs. Future research will determine the etiology of the remaining cases, further risk-stratify the known genetic defects, improve current treatment options for these syndromes, and uncover novel therapies.
To access this article, please choose from the options below
PII: S1050-1738(08)00125-4
doi:10.1016/j.tcm.2008.11.002
© 2008 Elsevier Inc. All rights reserved.
